Teva settles patent dispute with Lupin

Parsippanny-based Teva Pharmaceutical has reached an agreement with Lupin to resolve the dispute over Lupin’s abbreviated new drug application for a generic deutetrabenazine product.

Related Keywords

New Jersey , United States , Teva Austedo , Us District Court , Us Patent Office Trial , , Parsippanny Based Teva Pharmaceutical , Drug Administration Approved , Office Patent Trial , Appeal Board ,